Kane Biotech published a study in the International Wound Journal showing that revyve® Antimicrobial Wound Gel, used alongside standard care, improved healing outcomes in 17 patients with 28 chronic and complex wounds over 12 weeks. The wounds, which had persisted on average for 22 months and failed previous treatments, showed a 43.9% reduction in wound area, better wound bed tissue quality, improved fluid management, and a 54.4% reduction in patient-reported pain. The study supports further research into revyve's potential to enhance wound care, especially for difficult-to-heal wounds.
Kane Biotech's wound care study is the subject, with Pluang's health sector data providing market context. Of 150 priced US health stocks on Pluang, 118 rose and 24 fell as of Nov 04, 2026 18:41 WIB. Notable movers include Oscar Health Inc at USD 34.95 (+7.84%), Revvity Inc at USD 173.82 (+6.32%), and Nuvation Bio Inc at USD 4.98 (+6.18%).
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
Dimensional Fund Advisors Ltd. has disclosed an interest in 1,516,595 ordinary shares of DCC Energy plc, representing 1.78% of the company's shares as of November 3, 2026. The disclosure follows regulatory requirements under the Irish Takeover Panel ...
DDOG stock experienced a sharp decline of 18.8% within a single hour ending at 7:06 a.m. ET on November 4, trading at 183.78 USDT. This hourly drop was more severe than the stock's overall net decline across the full 24-hour period, highlighting a su...
